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Abstract
Background: Type 2 diabetes is very prevalent in the Gulf region, particularly in the United Arab Emirates (UAE)
which has the second highest prevalence in the world. Factors contributing to this include changes in diet,
adoption of sedentary lifestyles, and the consequent increase in rates of obesity. These changes are primarily due
to rapid economic development and affluence. The aim of this study was to estimate the prevalence of
psychological distress and its correlates in diabetic patients in the United Arab Emirates.
Methods: Patients diagnosed with diabetes attending diabetes mini-clinics in the primary health care centres or
hospitals of Sharjah were invited to participate in this cross-sectional study. Patients were interviewed using
structured questionnaires to gather data on socio-demographics, lifestyle factors, diabetes complications, and
medication usage. The K6 was administered as a screening tool for mental health concerns.
Results: Three hundred and forty-seven participants completed the interview. The majority of participants were
females (65.4%) and the mean age was 53.2 (sd = 14.6). Approximately 12.5% of patients obtained a score of 19 or
above (cut-off score) on the K6, indicating possible mental health concerns. Twenty-four percent had diabetes
complications, mainly in the form of retinopathy, peripheral vascular disease and peripheral neuropathy. A
significant relationship was found between scores on the K6, these complications of diabetes and the use of oral
hypoglycemic and lipid lowering therapies.
Conclusions: The results of this study demonstrate a strong correlation between mental health status and diabetic
complications. In particular, patients who are depressed tended to have poorer self-care, more severe physical
symptoms and were less likely to adhere to prescribed care regimens. These findings raise the possibility that
improving the mental health as part of a comprehensive management plan for diabetes may improve the overall
long term outcomes of these patients.
Background
Diabetes has been associated with an increased risk of
certain psychiatric disorders, particularly depression and
anxiety disorders [1]. Patients who have diabetes and a
comorbid psychiatric disorder are at increased risk of
poorer management and treatment outcomes than those
without a psychiatric disorder. Depression has been
associated with hyperglycemia [2] and an increased risk
for diabetic complications [3] and coronary heart disease
[4]. Diabetic patients with depression are also less likely
to adhere to medical treatment [5], and more likely to
have higher health care use and expenditures than dia-
betic patients without depression [6].
In a meta-analysis of 39 studies, Anderson et al. found
that patients with either type I or type II diabetes had
twice the likelihood of experiencing depression (11%
and 31% for major depression and elevated depression
symptoms respectively) than a matched group of non-
diabetic individuals, with the effect generalizing across
community and clinical settings [7]. The authors con-
cluded that one in every three individuals with diabetes
has depression that impairs their functioning, quality of
life and diabetic control.
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In a study of diabetes and anxiety in American adults,
Barker et al. reported that the overall age-adjusted pre-
valence of lifetime diagnosis of anxiety was 19.5% for
people with diabetes and 10.9% for those without dia-
betes. After statistical adjustment for educational level,
marital status, employment status, current smoking,
physical activity and body mass index, people with dia-
betes had a 20% higher prevalence of lifetime diagnosis
of anxiety than those without diabetes [8]. One limita-
tion of this study is that it did not detail specific anxiety
disorders.
The World Health Organization (WHO) emphasizes
the significance of the relationship between mental and
physical health. In their World Health Survey, WHO
concluded that depression produces the greatest detri-
ment in health compared with common chronic diseases
such as angina, arthritis, asthma, and diabetes. They also
reported that the comorbidity of depression with a
chronic illness incrementally worsens health outcomes
in comparison to depression alone, any chronic disease
alone, or any combination of chronic diseases in the
absence of depression [9].
A very high prevalence of obesity and Type 2 diabetes
has been identified in nationals of the Arabian Gulf coun-
tries in comparison to other areas of the world [10 ,11].
According to WHO, Saudi Arabia has the world’s third
highest rate of obesity (35.6%) followed by the United
Arab Emirates (UAE; 33.7%) [12]. Obesity is a major risk
factor for the development of diabetes and as such, the
UAE has one of the highest prevalence rates of diabetes
in the world, second only to Nauru [13]. A recent WHO
report on burden of disease estimates that the age-stan-
dardized DALYs (Disability-Adjusted Life Years) for dia-
betes in the UAE is 1,024 per 100,000, one of the highest
in the world [14].
In a study on diabetes conducted in the UAE, Saadi
et al. [13] randomly sampled households of Emirati citi-
zens in the city of Al-Ain. Of the 2455 adults surveyed,
10.2% reported having been diagnosed with diabetes
mellitus. The age-standardized rate for diabetes (diag-
nosed and undiagnosed) and pre-diabetes among 30-64
year old was estimated to be just over 50% (29% and
24.2%, respectively). A significant proportion of subjects
with undiagnosed diabetes and pre-diabetes also suffered
from vascular disease.
These high rates are likely related to marked eco-
nomic development, which has led to a decrease in total
mortality and an increase in life expectancy. At the
same time, this affluence has lead to the adoption of
unhealthy lifestyles resulting in a surge of chronic ill-
health, particularly type 2 diabetes and cardiovascular
diseases (CVD) [10,15]. These lifestyle changes include
decreased levels of activity and increased consumption
of calories which contribute to the development of
obesity, a major risk factor for diabetes and CVD [13].
The associated physical and mental health complications
of these phenomena are expected to have a significant
impact in the future [13].
In a study of primary care diabetic patients in Al-Ain,
United Arab Emirates, the authors found that 33.8% of
diabetic patients had psychiatric co-morbidity [16]. All
psychiatric cases were identified as mild or moderate in
severity. Depression was the most common disorder
(16.9% of diabetic patients) This was followed by mixed
anxiety and depressive disorder (9.9%) and generalized
anxiety disorder (7.0%) [16].
Despite the high prevalence of diabtes in the UAE,
limited attention has been given to the influence of
mental health on diabetes-related complications and
other diabetes-related variables [16]. It is important to
consider this variable due to its potential impact upon
disease progression, outcome, and even mortality. The
objectives of this study were to estimate the prevalence
of psychological distress and to identify its correlates
(i.e., demographics/lifestyle factors, diabetes complica-
tions, and medication usage) in a cross-sectional study
of diabetic patients in Sharjah, United Arab Emirates.
Methods
Setting and Participants
The study was a cross-sectional survey conducted in the
primary health care centres (PHC) in the Emirate of
Sharjah, United Arab Emirates during the period of
January 2007 to June 2008. The study was approved by
the Institutional Review Board of the Medical and
Health Sciences Colleges at the University of Sharjah
and was implemented in compliance with the Helsinki
Declaration. A research assistant approached patients
during the chronic diseases clinic days.She explained the
study to potential participants and obtained informed
consent. Patients with type 2 diabetes who were 18
years or older were invited to participate. Pregrant
women, patients with severe clinical or psychiatric mor-
bidity, patients who were unable to give written consent
and those who couldn’t communicate adequately in Ara-
bic or English language were excluded. Patients were
interviewed using a structured questionnaire on mental
health, demographics, life style factors, diabetes compli-
cations, and diabetes management. Physical activity
questions were based on frequency of a 15-minute vig-
orous activity and/or 30-minute moderate intensity
activity and/or walking during a usual 7-day period [17].
Patients’ medical records were reviewed and blood
(fasting blood sugar, heamoglobin A1c, cholesterol and
triglycerides, urea and creatinin)and urine test results
were obtained as well as body weight, height, waist cir-
cumference (to the nearest 1 mm), blood pressure and
management details.
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Measures
Mental Health
The mental health status was assessed using the Arabic
version of a widely accepted screening tool, the K6 [18].
This is a six-item self-report scale that assesses the fre-
quency with which an individual experiences symptoms
of general psychological distress such as nervousness,
tiredness, hopelessness, and restlessness that are asso-
ciated with serious mental illness. The score for each
item ranges from 1 (“none of the time”) to 5 ("all of the
time”). Summing the unweighted items yields a total
score that ranges from 6 to 30. The optimal cutoff point
is 6 to 18 versus 19+ [18]. The K6 scale has been vali-
dated in the Arabic language [19].
Statistical analyses
Descriptive analyses were completed by calculating the
number and percent of the categorical variables, and the
mean and standard deviation (sd) for the continuous vari-
ables. Continuous variables were categorized based on
clinical reasoning. Bivariate analyses were carried out to
assess the associations between two categorical variables
by using the Chi-squared test. Moreover, in order to iden-
tify the predictors of the mental health, as measured by
the K6, we carried out a multivariate logistic regression
analyses, where clinically relevant factors were included in
the model. In this analysis, odds ratios (OR), and 95% con-
fidence interval (95% CI) were calculated. Association
between a categorical variable and a continuous one was
carried out by calculating the student’s t-test. A p-value
less than 0.05 was considered statistically significant. Data
management and analyses was carried our using the Statis-
tical Package for Social Sciences (SPSS) version 16.
Results
Out of 490 patients invited, 347 (71%) participants con-
sented to participate in the study. Non participants were
mainly females who refused to participate due to lack of
time, confidentiality and literacy. The majority of partici-
pants were females (65.4%). The mean age was 53.2 (+/-
14.6) and the mean BMI was 29.8 (+/- 5.9). The large
majority were UAE nationals (83.9%), while the remain-
der originated from various countries including Pakistan
(3.5%), Egypt (2.6%) and other Arab countries (10%; i.e.,
Palestine, Lebanon, Yemen, Iraq, Syria, and Sudan). The
majority were married (87.9%). The majority were on
oral hypoglycemic medication (80.7%) and 62 (18.8%)
patients were on various forms of Insulin (Mixtard,
Humilin N, Humilin R). and 24% had established vascular
complications affecting mainly the eyes and lower limbs.
Mental Health Status of Participants
Approximately 12.5% of patients obtained a score of 19
or above (cutoff score) on the K6. While not diagnostic,
this score indicates the possible presence of psycho-
pathology in this group of patients, primarily depression
or anxiety disorder. Patients in the borderline range may
also be at risk of future mental health problems.
Association of Mental Health with Diabetes-Related
Variables
Association between mental health status, as measured
by the K6 score, with demographic, lifestyle variables,
diabetes-related complications, and medications are pre-
sented in Tables 1, 2, and 3. While there were no speci-
fic demographic or lifestyle factors significantly related
to mental health scores, nationality and marital status
bordered significance (p < .05). Nationalities other than
Emirati and unmarried patients had higher rates of
scores in the 19 and above. It should be noted that a
Table 1 Cross-tabulations of Demographics/Lifestyle
Variables and Categorization on K-6
Less than 19 19 and above
n % n % p value
Sex
Male 99 34.3 14 34.1
Female 190 65.7 27 65.9 .99
Age
Mean (sd) 53.2 14.6 53.2 15.8 .97
BMI
Mean (sd) 30.1 6.2 28.4 5.1 .13
Nationality
Emirati 246 85.1 30 73.2
Other 43 14.9 11 26.8 .053
Marital Status
Married 254 88.5 34 82.9 .052
Not married 33 11.5 7 17.1
Smoking
Current 10 3.5 1 2.4
Previous 9 3.1 2 4.9 .801
Never 268 93.4 38 92.7
Physical Activity
Yes 46 17.2 3 7.3
No 222 82.8 38 92.7 .108
Family History
Yes 70 28.5 10 27.8
No 167 67.9 22 61.1 .135
Not sure 9 3.7 4 11.1
Age at Diagnosis
Less than 46 53 20.6 10 24.4
46-55 80 31.1 11 26.8
56-65 77 30 8 19.5 .266
Above 65 47 18.3 12 29.3
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higher level of physical inactivity was found in this sam-
ple with 84.1% indicating that they had not walked
within the past 7-day. While the relationship was not
significant, the trend was toward a higher risk for men-
tal health concerns in those who were inactive.
Similarly, the mean K6 score was higher in patients
with poorer diabetes control [HbA1c >7 (mean K6 =
11.65) compared with better controlled diabetes HbA1c
< 7 (mean K6 = 11.56), but the relation did not reach
statistical significance, p = .07]. The mean systolic and
diastolic blood pressure followed similar trends, but was
not statistically significant. The mean systolic and dia-
stolic blood pressure was 130 versus 135 and 79.2 versus
81.3 in lower and higher K6 scores respectively, but was
not statistically significant (p = 0.13 for systolic and p =
0.17 for diastolic).
In relation to diabetes-related complications, two vari-
ables were found to be significantly related to K6 scores.
These variables were eye-related complications (retinopathy
and glaucoma) (p < .034), and vascular/neurological com-
plications in the lower limbs (p < .005). Other complication
variables were found to be insignificant due to low num-
bers. For diabetes-related medications, two categories were
found to be significantly associated with K6 scores, oral
hypoglycemics and antihyperlipidemics, but not insulin.
Predictors of Mental health
Table 4 summarizes the results of the multivariate logis-
tic regression analyses. Out of all the variables included
in the model, the only significant predictors of K6 being
more than 19 was found to be hypertension (OR = 2.53,
95% CI: 1.08-5.92, p-value = 0.03) and complications of
the eyes (OR = 3.38, 95% CI: 1.01-11.32, p-value =
0.05). On the other hand, complications in the feet was
found to be of border-line significance (OR = 2.24, 95%
CI: 0.98-5.11, p-value = 0.06). All the other variables
included in the model were not found to be statistically
significant.
Discussion
The results indicate that patients with higher scores on
K6 having poorer diabetes control than those with lower
scores on K6, which is supported by the fact that patients
Table 2 Cross-tabulations of Diabetes-Related
Complications and Categorization on K-6
Less than 19 19 and above
n % n % p value
Eyes1
Yes 16 24.2 7 58.3
No 50 75.8 5 41.7 .034*
Feet2
Yes 56 53.3 16 88.9 .005*
No 16 88.9 2 11.1
Kidney3
Yes 1 1.8 1 16.7
No 54 98.2 5 83.3 .189
Stroke4
Yes 3 5.3 0 0 1.00
No 54 94.7 5 100
Amputation5
Yes 2 3.6 1 16.7
No 54 96.4 5 83.3 .267
Heart Problems6
Yes 4 6.9 1 16.7 .399
No 54 93.1 5 83.3
Heart Problems-Other
Yes 1 1.9 0 0
No 53 98.1 5 100 1.00
1Glaucoma, laser surgery, eye bleeding.
2Gangrene, loss of sensation/numbness/pain/burning/tingling.
3Protein or albumin in urine.
4Loss of sensation one side of body, difficulty speaking/eating, facial drop,
paralyzed arm or leg.
5Loss of toe, foot or leg
6Angina, chest pain, heart attack, etc.
Table 3 Cross-tabulations of Diabetes-Related
Medications and Categorization on K-6
Less than 19 19 and above
n % n % p value
Oral Hypoglycemics
Yes 205 88.0 32 82.5
No 28 12.0 7 17.5 .032*
Diuretics
Indapamide 29 90.6 4 100 .815
Frusemide 2 6.3 0 0
Betablockers
Atenolol 50 8 53.3 2 66.7
Atenolol 100 6 40 1 33.3 .857
ACE Inhibitors
Yes 61 21.1 7 17.1 .550
No 228 78.9 34 82.9
Receptor blocker
Losartan 22 78.6 6 85.7
Valsartan 6 21.4 1 14.3 .673
Calcium channel blockers
Amilodipine 16 72.7 1 50
Nifedipine 4 18.2 1 50 .547
Verapamil 2 9.1 0 0
Antihyerlipidemics
Yes 89 30.8 20 48.8 .022*
No 200 69.2 21 51.2
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with higher K6 scores (depression and anxiety combined)
were more likely to have eye-related complications (reti-
nopathy and glaucoma) and vascular/neurological com-
plications in the lower limbs. These types of
complications would correspond to diseases of retinopa-
thy and neuropathy respectively.
The results of this study support research that has
been conducted thus far regarding the relationship
between mental health and diabetes control and compli-
cations. Researchers in the area have concluded that
depression, in particular, tends to predict poor diabetes
control [20]. In their meta-analysis of 27 studies, de
Groot et al. reported a significant correlation between
depression and a variety of diabetes complications,
including diabetic retinopathy, nepropathy, neuropathy,
macrovascular complications and sexual dysfunction [3].
The current research extends these results to an Arab
sample in the Arabian Gulf region. These results are sig-
nificant as minor and major depressive disorders in
patients with diabetic foot ulcer have been associated
with threefold hazard risk for mortality compared with
no depression [24]. Both minor and major depression
have been strongly associated with increased mortality
overall for diabetic patients [25]. It is important to keep
in mind that the direction of the relationship may also
be in the opposite direction, in that severe complications
may increase the likelihood of depressive or anxious
symptoms.
The outcomes of this study highlight the importance
of assessing and treating comorbid mental health con-
cerns as part of a comprehensive management plan for
diabetes [23]. Treating both co-morbid illnesses simulta-
neously enhances the likelihood of a successful outcome
due to synergistic effects wherein the treatment of one
condition affects the course of the other [24]. Due to
the cross-sectional nature of the study, it is difficult to
determine the exact causal nature of this relationship,
but it is likely to be reciprocal. Negative life events, lack
of social support, and stress are very likely to aggravate
the problems [25].
Patients who are depressed struggle with self-care and
adherence to their prescribed care regimens [5,26]. They
also often have more severe physical symptoms than
patients who are not depressed [3]. This fact was sup-
ported by the results of this study, specifically the strong
correlation between mental health status and vascular
and neurological diabetic complications. As with
patients who experience other chronic medical condi-
tions, patients with diabetes often have worse symptoms
of depression and respond less well to depression treat-
ment. Depressive symptoms also increase with the
severity of the illness [7].
Depressed and anxious patients are more likely to have
unhealthy behaviors, such as smoking, overeating, and
insufficient physical activities [27]. This would be an
additional rationale for targeting depression early in the
treatment program. Depressed patients are unlikely to
have the energy or motivation to engage in behavior or
lifestyle change efforts. Once the depression or anxiety
has been addressed, behavior change programs may be
initiated. Various cultural factors may influence this vari-
able and may need to be addressed in the management
process to enhance compliance [28]. Self-management
programs should be initiated in this context and include
methods to assist patients with coping with their chronic
illness.
While depression and anxiety are common in patients
with diabetes, they are often inadequately treated [24].
Effective treatments for depression and anxiety are avail-
able, including psychotherapy and pharamacotherapy, so
it is important to augment conventional diabetes treat-
ment with these evidence-based therapies that contri-
bute to improved diabetes outcomes [23]. This may
enhance glycemic control, reduce the risk of complica-
tions and help to preserve the physical health and inde-
pendence of diabetic patients [23].
One of the challenges in relation to screening, diag-
noses and treatment of mental health problems in this
region is that mental illness and the utilization of mental
health services are highly stigmatized in the culture.
This applies to any type of mental health problem, parti-
cularly more severe ones, and most types of services
(psychiatric, psychological, family and marital therapies)
[29]. There is also tendency for somatisation as it is
more culturally acceptable to express physical symptoms
than psychological [29,30].
The Islamic religion also has a profound impact upon
the mental health beliefs and practices of people in the
Table 4 Logistic regression analyses for the predictors of
Categorization on K-6
Variable OR 95% CI P-value
Age 1.01 0.98-1.04 0.48
Sex 1.08 0.50-2.33 0.85
Nationality 1.44 0.57-3.62 0.44
Consanguinity 1.76 0.62-5.00 0.29
Marital status 2.02 0.61-6.75 0.25
BMI 0.96 0.89-1.03 0.25
Systolic Blood Pressure 1.02 0.99-1.05 0.12
Diastolic Blood Pressure 1.03 0.98-1.08 0.23
Hypertension 2.53 1.08-5.92 0.03
Complications: eyes 3.38 1.01-11.32 0.05
Complications: feet 2.24 0.98-5.11 0.06
Complications: kidney 3.79 0.19-74.56 0.38
Complications: amputation 4.46 0.20-100.72 0.35
Complications: heart 2.08 0.16-27.73 0.58
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region. For example, people tend to believe that mental
illness is associated with supernatural influences, such as
jinn, the evil eye, or magic, rather than physical or bio-
medical [29]. Many also believe that a mental illness
may be divine punishment as a result of disobedience or
sin, or due to weak faith [29]. The prevalent belief in
God’s will as determining events results in afflicted indi-
viduals turning to God in prayer, supplication, religious
remedies, or religious leaders, often in disregard to the
medical or psychological treatments available [31]. This
is an incorrect belief as the various treatments are part
of God’s decree as well.
There are several limitations of the current study
including its cross-sectional nature. This results in diffi-
culty in delineating the causal relationship between the
variables. Specifically, diabetes management may lead to
the development of depressive symptoms and, in turn,
depression may worsen diabetic management and com-
plications. The relationship is very likely to be reciprocal
and synergistic. The sample was a non-random, conve-
nient sample and the non response may have introduced
bias into the results and limit generalizability. The study
also did not include a control group thus limiting its
overall power. Patient’s literacy level may have affected
response due to social desirability or poor understanding
of the issues. Finally, it is important to note that the K6
is only a screening tool and is not diagnostic of depres-
sion or other psychiatric disorders.
Conclusion
With these limitations in mind and in conclusion, we have
identified a percentage of diabetic patients in Sharjah who
are likely to be either depressed or anxious or both. We
have also indicated that these mental health problems are
more prevalent in patients with diabetes-related retinopa-
thy and neurovascular complications, suggesting a strong
correlation between mental health status and diabetic
complications. These findings indicate that improving the
mental health as part of a comprehensive management
plan for diabetes may improve the long term outcomes of
these patients. We have highlighted a few strategies that
may help physicians deal more efefctively with such
patients.
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